https://www.europesays.com/at/462765/ Suzertrigin (Journavx): FDA-zugelassener NaV1.8-Blocker als neue Non-Opioid-Option #AI #Am3 #Analgetikum #Ara290 #ARTIFICIALINTELLIGENCE #AT #Austria #DirkTrauner #Dsip #FDA #Gesundheit #Health #InsilicoMedicine #Ism9528 #Jornavx #KI #KünstlicheIntelligenz #Nav18 #Neefopamhydrochlorid #Opioidfrei #Österreich #Pea #Pharmakologie #Photopharmakologie #Schmerztherapie #Suzertrigin #VertexPharmaceuticals
#neefopamhydrochlorid — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #neefopamhydrochlorid, aggregated by home.social.